The ADA guidelines are supported by Regence because they are based on scientific evidence, and where evidence is lacking, on panel consensus judgment. The report reflects the current standard of care.
The panel members are recognized experts practicing in a variety of professional settings.
The guidelines clearly state the strength of the evidence for which recommendations are based.
Methods used to search for and select appropriate scientific literature are not readily apparent.
The methods used to critically appraise the evidence supporting guideline recommendations are not transparent.
Financial disclosures/potential conflicts of interest for panel members are included in the evidence report, although sources of funding for the guidelines are not disclosed.
Some Regence members may be eligible for participation in the diabetes disease management program. Please check benefits for eligibility.
Diabetes educational materials are included on the Regence website: myregence.com
Guideline Adoption and Recommended Use: This guideline has been adopted based on nationally and locally recognized sources. This guideline is based on the most recent medical evidence at the time of the report or on a consensus of panel experts. Regence adopts guidelines to help practitioners and members make decisions about appropriate health care for specific conditions. Guidelines are not a substitute for professional medical advice.
Benefit Determination: Benefit determinations should be based in all cases on the applicable contract coverage. To the extent that there are any conflicts between these guidelines and the contract language, the contract language takes precedence.
The Blue Cross and/or
Blue Shield Plans comprising The Regence Group serve Idaho, Oregon,
Utah and much of Washington state.
Group and each of its affiliate Plans are independent licensees of
the Blue Cross and Blue Shield Association.